Tolerability of the soybeverage and compliance were assessed.
2
Mean consumption of the assigned soybeverage was 93%.
3
Our objective was to evaluate the tolerability and effect of a daily soybeverage in prostate cancer patients with biochemical failure after radiotherapy.
4
Patients with rising prostate-specific antigen (PSA) after radical radiation for prostate cancer were instructed to consume 500 ml of soybeverage daily for 6 mo.